U.S. flag

An official website of the United States government

NM_000238.4(KCNH2):c.1894C>G (p.Pro632Ala) AND Long QT syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 15, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001362441.6

Allele description [Variation Report for NM_000238.4(KCNH2):c.1894C>G (p.Pro632Ala)]

NM_000238.4(KCNH2):c.1894C>G (p.Pro632Ala)

Gene:
KCNH2:potassium voltage-gated channel subfamily H member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q36.1
Genomic location:
Preferred name:
NM_000238.4(KCNH2):c.1894C>G (p.Pro632Ala)
HGVS:
  • NC_000007.14:g.150951499G>C
  • NG_008916.1:g.31428C>G
  • NM_000238.4:c.1894C>GMANE SELECT
  • NM_001204798.2:c.874C>G
  • NM_001406753.1:c.1606C>G
  • NM_001406755.1:c.1717C>G
  • NM_001406756.1:c.1606C>G
  • NM_001406757.1:c.1594C>G
  • NM_172056.3:c.1894C>G
  • NM_172057.3:c.874C>G
  • NP_000229.1:p.Pro632Ala
  • NP_000229.1:p.Pro632Ala
  • NP_001191727.1:p.Pro292Ala
  • NP_001393682.1:p.Pro536Ala
  • NP_001393684.1:p.Pro573Ala
  • NP_001393685.1:p.Pro536Ala
  • NP_001393686.1:p.Pro532Ala
  • NP_742053.1:p.Pro632Ala
  • NP_742053.1:p.Pro632Ala
  • NP_742054.1:p.Pro292Ala
  • NP_742054.1:p.Pro292Ala
  • LRG_288t1:c.1894C>G
  • LRG_288t2:c.1894C>G
  • LRG_288t3:c.874C>G
  • LRG_288:g.31428C>G
  • LRG_288p1:p.Pro632Ala
  • LRG_288p2:p.Pro632Ala
  • LRG_288p3:p.Pro292Ala
  • NC_000007.13:g.150648587G>C
  • NM_000238.3:c.1894C>G
  • NM_172056.2:c.1894C>G
  • NM_172057.2:c.874C>G
  • NR_176254.1:n.2302C>G
  • NR_176255.1:n.1175C>G
Protein change:
P292A
Links:
dbSNP: rs199473527
NCBI 1000 Genomes Browser:
rs199473527
Molecular consequence:
  • NM_000238.4:c.1894C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001204798.2:c.874C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406753.1:c.1606C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406755.1:c.1717C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406756.1:c.1606C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406757.1:c.1594C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172056.3:c.1894C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172057.3:c.874C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Long QT syndrome (LQTS)
Identifiers:
MONDO: MONDO:0002442; MeSH: D008133; MedGen: C0023976

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001558457Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Sep 15, 2021)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations.

Mullally J, Goldenberg I, Moss AJ, Lopes CM, Ackerman MJ, Zareba W, McNitt S, Robinson JL, Benhorin J, Kaufman ES, Towbin JA, Barsheshet A.

Heart Rhythm. 2013 Mar;10(3):378-82. doi: 10.1016/j.hrthm.2012.11.006. Epub 2012 Nov 19.

PubMed [citation]
PMID:
23174487
PMCID:
PMC3690288

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001558457.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This missense change has been observed in individual(s) with Long QT syndrome (PMID: 23174487). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with alanine at codon 632 of the KCNH2 protein (p.Pro632Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024